ID: MRFR/Pharma/4173-HCR | 100 Pages | Published By Rahul Gotadki on March 2023
Hypotension refers to very low blood pressure and affects people across all age groups. Blood pressure is the force exerted by human blood against the artery walls, while blood is pumped out by the heart
Hypotension refers to very low blood pressure and affects people across all age groups. Blood pressure is the force exerted by human blood against the artery walls, while blood is pumped out by the heart. Hypotension is normally characterized by a diastolic pressure that is lower than 60mm Hg. A systolic pressure lower than 90 mm Hg is also typically symptomatic of hypotension.
The global hypotension market is propelled by hypotension incidences, diabetes, cardiovascular disorders, and other health issues. When patients suffer from low blood pressure or hypotension, they may feel dizziness while standing up after sitting for long periods of time. This is why, many of them are advised to not rise suddenly and take support/more time to stand up without any discomfort.
Hypotension can also result from dehydration, nervous disorders, and endocrine issues. The geriatric population is quite susceptible to suffering from low blood pressure, boosting the rates of hospitalization and driving the industry. Apart from the elderly population, postpartum mothers and teenagers are also affected by hypotension. Rising population contributes to stress and lifestyle illnesses, leading to the demand for advanced treatments.
In addition to the above factors, the advent of novel participants (companies investing in hypotension treatments) and wider technological adoption should drive market growth. With the industry predicted to experience decent expansion over the forecast period, the side-effects of hypotension medicines can prevent further growth.
Considering the side-effects, many patients resort to alternative treatments and exercises. Patients need to assess whether they can tolerate the harmful effects of these medicines and decide for themselves. Every patient is different and what is suitable for someone may not be ideal for others. That said, exercising conveniently & regularly under the doctor’s guidance could yield very good results.
Some of the other propellers of the hypotension treatment market are the need for cardiovascular devices and poor eating habits. On the other hand, what has restricted the industry from progressing more is the lack of proficient medical professionals. Also, huge expenditures in the detection & management of cardiovascular disorders hamper the industry.
The “World Health Organization” (WHO) states that approximately 59 percent of the overall mortality rates stem from chronic illnesses globally. The prevalence of diabetes and cardiac disorders is adding more burden on developed & emerging regions. The targeted audiences of the hypotension treatment industry comprise research laboratories, manufacturers, research & development firms, potential spenders, and market research & consultation services.
The worldwide market is divided on account of indications, products, end-users, and regions. Coronary heart diseases, hypotension, and others constitute the indications. The products consist of blood pressure transducers, sphygmomanometers, blood pressure devices, etc. By end-users, the industry is fragmented on the basis of diagnostic centers, home care, hospitals & clinics, and others. According to regions, the global hypotension treatment market is divided further into Europe, Americas, the Middle East & Africa, and Asia Pacific.
“Americas” has generated the largest shares and its diabetic & cardiovascular incidences have accounted for the same. Europe is the second biggest market and driven by larger medical expenses & patient groups. Asia Pacific is projected to witness the fastest expansion till 2027. The Middle East & Africa would grow stably owing to its need for therapeutic & diagnostic centers.
Back in December 2017, the United States “FDA” (“Food and Drug Administration”) sanctioned the adoption of Giapreza injections. These injections have been developed to raise the blood pressure of patients suffering from hypotension. However, Giapreza is also known to have side-effects. In case of blood clots through its usage, prophylactic treatments are recommended. Other firms spending capital on the expansion of the worldwide hypotension treatment market include A & D medical, Schiller AG, American Diagnostic Corporation, Spacelabs Healthcare, and OMRON Corporation. They engage in product & therapeutic developments to generate higher sales & maintain an edge over the others.